Top Sell
| Security | Buy | Sell | Buy (1M) ▲ | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Organovo Holdings Inc. | 0 | 8 | 0 | 0 | €0.54 | - | - |
| Promis Neurosciences Inc. | 0 | 1 | 0 | 0 | €1.08 | €1.20 | 11.111% |
| Cellectar BioSciences Inc. | 5 | 4 | 0 | 0 | €1.98 | €11.09 | 460.182% |
| AEterna Zentaris Inc. | 2 | 22 | 0 | 2 | €1.87 | €8.51 | 355.096% |
| Shin Nippon Biomedical Laboratories Ltd. | 0 | 1 | 0 | 0 | €7.50 | - | - |
| Cardiff Oncology Inc. | 2 | 4 | 0 | 0 | €2.09 | €5.00 | 139.808% |
| NanoVibronix Inc. | 0 | 1 | 0 | 0 | €0.50 | - | - |
| Trevena Inc. | 2 | 23 | 0 | 3 | €0.15 | €6.48 | 4136.601% |
| Sage Therapeutics Inc. | 5 | 2 | 0 | 0 | €7.63 | €21.44 | 180.827% |
| BioLine RX Ltd ADR | 0 | 1 | 0 | 0 | €0.56 | - | - |
| Biofrontera AG | 0 | 1 | 0 | 0 | €0.33 | - | - |
| T2 Biosystems Inc. | 0 | 4 | 0 | 0 | €0.16 | - | - |
| Synthetic Biologics Inc. | 0 | 1 | 0 | 0 | €0.12 | - | - |
| Medigene AG | 1 | 1 | 0 | 0 | €1.06 | - | - |
| Amarin Corp. ADR | 2 | 1 | 0 | 0 | €0.58 | - | - |
| Viking Therapeutics Inc | 5 | 1 | 0 | 1 | €58.02 | - | - |
| Protalix Biotherapeutics Inc. | 1 | 1 | 0 | 0 | €0.85 | €2.00 | 135.183% |
| Enzo Biochem. Inc. | 0 | 1 | 0 | 0 | €1.00 | - | - |
| Natural Alternat. | 19 | 1 | 0 | 0 | €4.74 | - | - |
| Bristol-Myers Squibb | 7 | 3 | 0 | 1 | €45.21 | €67.64 | 49.627% |
| InVivo Therapeutics Holdings | 0 | 13 | 0 | 0 | €0.31 | - | - |
| Palisade Bio Inc. | 3 | 1 | 0 | 0 | €0.34 | €21.06 | 6072.333% |
| Xenon Pharmaceuticals Inc. | 1 | 1 | 0 | 0 | €36.20 | €50.00 | 38.122% |
| Uniqure B.V. | 1 | 2 | 0 | 0 | €5.29 | €11.00 | 108.018% |
| Nevro Corp. | 1 | 4 | 0 | 1 | €5.60 | €13.77 | 145.909% |